Pradofloxacin

Pradofloxacin
[[File: Chemical structure of Pradofloxacin |frameless|220px|alt=|]]
INN
Drug class
Routes of administration	Oral
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Pradofloxacin is a fluoroquinolone antibiotic used in veterinary medicine. It is specifically designed for use in cats and dogs to treat a variety of bacterial infections. Pradofloxacin is marketed under the trade name Veraflox.

Mechanism of Action

Pradofloxacin, like other fluoroquinolones, works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication, transcription, repair, and recombination. This inhibition leads to the disruption of bacterial cell division and ultimately results in bacterial cell death.

Spectrum of Activity

Pradofloxacin is effective against a broad range of Gram-positive and Gram-negative bacteria. It is particularly useful in treating infections caused by Staphylococcus, Streptococcus, and certain anaerobic bacteria. Its broad-spectrum activity makes it a valuable option for treating mixed infections in veterinary patients.

Clinical Uses

Pradofloxacin is primarily used in veterinary medicine for the treatment of:

• Skin infections in dogs and cats
• Urinary tract infections
• Respiratory tract infections
• Wound infections

Administration and Dosage

Pradofloxacin is administered orally, and the dosage varies depending on the type and severity of the infection, as well as the species and weight of the animal. It is important to follow the veterinarian's prescription to ensure effective treatment and minimize the risk of resistance.

Side Effects and Precautions

Common side effects of pradofloxacin may include gastrointestinal disturbances such as vomiting and diarrhea. As with other fluoroquinolones, there is a risk of cartilage damage in young, growing animals, so its use is generally avoided in puppies and kittens. Pradofloxacin should be used with caution in animals with known seizure disorders.

Resistance

Bacterial resistance to fluoroquinolones, including pradofloxacin, can develop through various mechanisms, such as mutations in the target enzymes or efflux pump overexpression. Responsible use of pradofloxacin, including adherence to prescribed dosages and treatment durations, is essential to minimize the development of resistance.

Related Pages

• Fluoroquinolone
• Antibiotic resistance
• Veterinary medicine